Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - malay haldar
Targeting the retinoic acid pathway to bolster immunotherapy
A strategy to increase the effect of immune checkpoint blockade by targeting retinoic acid signaling in immunosuppressive solid tumors. Technology Overview: Sarcomas are solid tumors with more than 70 rare and often fatal subtypes. Typical survival rates are under 15% over 5 years. Sarcomas can prevent the formation of tumor-killing cells by eluding...
Therapeutics & Vaccines
© 2020. All Rights Reserved. Powered by